IRIDEX (IRIX) Competitors $1.34 0.00 (0.00%) As of 03:40 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock IRIX vs. BDMD, APYX, VANI, NTRB, TELA, LUNG, QTI, CTSO, MDAI, and PYPDShould you be buying IRIDEX stock or one of its competitors? The main competitors of IRIDEX include Baird Medical Investment (BDMD), Apyx Medical (APYX), Vivani Medical (VANI), Nutriband (NTRB), TELA Bio (TELA), Pulmonx (LUNG), QT Imaging (QTI), Cytosorbents (CTSO), Spectral AI (MDAI), and PolyPid (PYPD). These companies are all part of the "medical equipment" industry. IRIDEX vs. Its Competitors Baird Medical Investment Apyx Medical Vivani Medical Nutriband TELA Bio Pulmonx QT Imaging Cytosorbents Spectral AI PolyPid Baird Medical Investment (NASDAQ:BDMD) and IRIDEX (NASDAQ:IRIX) are both small-cap medical equipment companies, but which is the better business? We will compare the two businesses based on the strength of their media sentiment, earnings, dividends, valuation, institutional ownership, profitability, risk and analyst recommendations. Do institutionals & insiders believe in BDMD or IRIX? 19.8% of Baird Medical Investment shares are owned by institutional investors. Comparatively, 20.1% of IRIDEX shares are owned by institutional investors. 78.9% of Baird Medical Investment shares are owned by company insiders. Comparatively, 7.4% of IRIDEX shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Is BDMD or IRIX more profitable? Baird Medical Investment has a net margin of 0.00% compared to IRIDEX's net margin of -10.95%. Baird Medical Investment's return on equity of 0.00% beat IRIDEX's return on equity.Company Net Margins Return on Equity Return on Assets Baird Medical InvestmentN/A N/A N/A IRIDEX -10.95%-386.93%-17.42% Which has better valuation and earnings, BDMD or IRIX? Baird Medical Investment has higher earnings, but lower revenue than IRIDEX. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBaird Medical Investment$37.04M2.36N/AN/AN/AIRIDEX$48.67M0.47-$8.91M-$0.33-4.06 Does the media refer more to BDMD or IRIX? In the previous week, Baird Medical Investment and Baird Medical Investment both had 1 articles in the media. Baird Medical Investment's average media sentiment score of 1.88 equaled IRIDEX'saverage media sentiment score. Company Overall Sentiment Baird Medical Investment Very Positive IRIDEX Very Positive Which has more volatility & risk, BDMD or IRIX? Baird Medical Investment has a beta of -0.98, indicating that its stock price is 198% less volatile than the S&P 500. Comparatively, IRIDEX has a beta of 0.63, indicating that its stock price is 37% less volatile than the S&P 500. SummaryBaird Medical Investment beats IRIDEX on 5 of the 8 factors compared between the two stocks. Get IRIDEX News Delivered to You Automatically Sign up to receive the latest news and ratings for IRIX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IRIX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IRIX vs. The Competition Export to ExcelMetricIRIDEXLASERS IndustryComputer SectorNASDAQ ExchangeMarket Cap$22.77M$1.02B$29.57B$9.65BDividend YieldN/AN/A3.18%4.53%P/E Ratio-4.06N/A416.3026.32Price / Sales0.4754.471,683.93210.95Price / CashN/A27.9934.2828.92Price / Book10.315.726.986.04Net Income-$8.91M-$60.02M$807.18M$265.75M7 Day Performance5.51%0.38%-0.59%-0.35%1 Month Performance4.69%-1.82%3.53%5.55%1 Year Performance-33.33%8.88%23,981.78%17.44% IRIDEX Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IRIXIRIDEX1.1637 of 5 stars$1.34flatN/A-33.3%$22.77M$48.67M-4.06120BDMDBaird Medical InvestmentN/A$2.39+3.9%N/AN/A$82.18MN/A0.00N/APositive NewsAPYXApyx Medical1.8588 of 5 stars$2.06-1.4%N/A+49.6%$77.91M$46.51M-4.58270VANIVivani Medical2.3449 of 5 stars$1.23-0.8%$4.00+225.2%-12.2%$73.46MN/A-2.7320Analyst ForecastShort Interest ↓NTRBNutriband3.3298 of 5 stars$6.41-0.3%$13.00+102.8%+58.6%$71.44M$2.40M-7.1210Short Interest ↑Gap DownTELATELA Bio3.038 of 5 stars$1.83+3.4%$4.50+145.9%-38.6%$70.12M$75.32M-1.63120Positive NewsLUNGPulmonx4.0932 of 5 stars$1.67-1.2%$7.66+358.9%-76.6%$68.86M$90.55M-1.17250News CoverageAnalyst UpgradeGap DownQTIQT ImagingN/A$2.13+0.5%N/A+265.2%$57.80M$4.00M0.00N/ANews CoverageCTSOCytosorbents2.0284 of 5 stars$0.91-0.7%$5.50+506.9%-10.2%$57.31M$35.60M-5.33220Positive NewsMDAISpectral AI3.2134 of 5 stars$2.03-2.9%$3.50+72.4%+35.0%$55.87M$29.58M-2.9483PYPDPolyPid2.3147 of 5 stars$3.45-1.4%$12.40+259.4%-5.6%$55.64MN/A-0.9080News CoveragePositive NewsShort Interest ↑High Trading Volume Related Companies and Tools Related Companies BDMD Alternatives APYX Alternatives VANI Alternatives NTRB Alternatives TELA Alternatives LUNG Alternatives QTI Alternatives CTSO Alternatives MDAI Alternatives PYPD Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IRIX) was last updated on 9/2/2025 by MarketBeat.com Staff From Our Partners[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredGENIUS Act: Cancel Your Money?They said digital dollars were off the table. But with the GENIUS Act now federal law, private corporations—no...Priority Gold | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IRIDEX Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share IRIDEX With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
